These series of findings indicate that Her2+ cancer cells may be capable of generating SDF-1–producing CAFs that, in turn, influence tumor growth and progression, potentially resulting in poor outcomes in breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.